1. The role of the tumor stroma in ovarian cancer.
   Ben Davidson et al, 2014, Front Oncol CrossRef
2. Ovarian cancer: involvement of the matrix metalloproteinases.
   Linah Al-Alem et al, 2015, Reproduction CrossRef
3. Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
   Aneta Cymbaluk-Płoska et al, 2018, J Ovarian Res CrossRef
4. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression
   Ruth Escalona et al, 2018, IJMS CrossRef
5. Expression of pro-apoptotic markers is increased along the osteochondral junction in naturally occurring osteochondrosis
   Stacy A. Semevolos et al, 2018, Bone Reports CrossRef
6. Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis
   Dominique Trudel et al, 2014, Mod Pathol CrossRef
7. The prognostic values of matrix metalloproteinases in ovarian cancer
   Linchai Zeng et al, 2019, J Int Med Res CrossRef
8. Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival
   M. Caroline Vos et al, 2019, CBM CrossRef
9. Prognostic Value of MMP-9 in Ovarian Cancer: A Meta-analysis
   Li-Na Li et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef
10. Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast
    Kyueng-Whan Min et al, 2014, APMIS CrossRef
11. Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis
    Patrice Desmeules et al, 2015, Human Pathology CrossRef
12. The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
    Ziyi Fu et al, 2015, International Journal of Gynecological Cancer CrossRef
13. MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions
    Ben Davidson et al, 2016, Human Pathology CrossRef
14. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer
    M. Caroline Vos et al, 2016, Diagn Pathol CrossRef
15. MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
    Maria Caroline Vos et al, 2016, J Ovarian Res CrossRef
16. Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma
    Tomonori Sasahira et al, 2017, Histopathology CrossRef
17. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy
    Alessandra Ferraresi et al, 2017, Mol. Carcinog. CrossRef
18. Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer
    Boris Bumber et al, 2019, Clin Otolaryngol CrossRef
19. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
    Manuel Abreu et al, 2020, Cells CrossRef
20. TPX2 silencing mediated by joint action of microvesicles and ultrasonic radiation inhibits the migration and invasion of SKOV3 cells
    Dong Huang et al, 2018, Mol Med Report CrossRef
21. miR‑377 targets CUL4A and regulates metastatic capability in ovarian cancer.
    Rufen Yu et al, 0 CrossRef
22. Cisplatin induced testicular damage through mitochondria mediated apoptosis, inflammation and oxidative stress in rats: impact of resveratrol
    Hamdy A.A. Aly et al, 2020, Endocr J CrossRef
23. Mitochondria-Mediated Apoptosis Induced Testicular Dysfunction in Diabetic Rats: Ameliorative Effect of Resveratrol
    Hamdy A A Aly, 2021 CrossRef
24. Characteristics of Selected Adipokines in Ascites and Blood of Ovarian Cancer Patients
    Marcin Wróblewski et al, 2021, Cancers CrossRef
25. Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
    Ruth M. Escalona et al, 2022, Front. Oncol. CrossRef
26. Prognostic utility of the ovarian cancer secretome: a systematic investigation
    Pradnya R. Kamble et al, 2022, Arch Gynecol Obstet CrossRef
27. Diagnosis and Prediction of Endometrial Carcinoma Using Machine Learning and Artificial Neural Networks Based on Public Databases
    Dongli Zhao et al, 2022, Genes CrossRef
28. Differential Protein Expression of the Marginal Transitional Zone in Foals with Osteochondrosis
    Elizabeth A Marchant et al, 2022, Journal of Equine Veterinary Science CrossRef
29. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells
    Maryam Momen Razmgah et al, 2022, Mol Biol Rep CrossRef
30. Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
    Aleksandra Kicman et al, 2022, CMAR CrossRef
31. Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis
    Changyu Liu et al, 2022, Int J Biol Markers CrossRef
32. Role of cartilage and bone matrix regulation in early equine osteochondrosis
    S.K. Grissom et al, 2023, Bone Reports CrossRef